Adam Veness
General Counsel bei DIANTHUS THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Aktive Positionen von Adam Veness
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | General Counsel | 11.09.2023 | - |
| Corporate Secretary | 11.09.2023 | - |
Karriereverlauf von Adam Veness
Ehemalige bekannte Positionen von Adam Veness
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CYTEIR THERAPEUTICS, INC. | General Counsel | 25.04.2022 | 14.06.2023 |
| Corporate Secretary | - | 14.06.2023 | |
| ACCELERON PHARMA INC. | Compliance Officer | 01.07.2014 | 01.06.2019 |
| General Counsel | 01.06.2019 | 01.12.2021 | |
| Corporate Secretary | 01.06.2019 | - | |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.01.2012 | 01.07.2014 |
Ausbildung von Adam Veness
| Tulane University (Louisiana) | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| General Counsel | 3 |
| Corporate Secretary | 3 |
| Compliance Officer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CYTEIR THERAPEUTICS, INC. | Health Technology |
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Commercial Services |
- Börse
- Insiders
- Adam Veness
- Erfahrung
